PITTSBURGH, Sept. 7, 2011 (GLOBE NEWSWIRE) -- ChemImage announced today that it is one of six companies selected to receive up to $1 million in funding from the Ohio Third Frontier Advanced Materials Program, a program devoted to accelerating the development and growth of the advanced materials industry in Ohio. The award will be used to establish a manufacturing facility for its patented multi-conjugate filter (MCF) technology.
Based on liquid crystal technology, these unique tunable filters are the key component of the company's hyperspectral imaging instrumentation used to characterize the material composition of samples crossing multiple industries.
"The assistance we receive from Ohio Third Frontier will be an important step in establishing ChemImage in an area of Ohio that's well established in the liquid crystal community," said Dr. Thomas Voigt, Executive Vice President of ChemImage & Head of Imaging Technology. "Our new manufacturing facility will make the best use of this knowledge that's unique to Northeast Ohio, giving our company a competitive advantage in the diverse markets that we serve."
ChemImage partnered with Kent State University's Liquid Crystal Institute, the world's first research center focused on the science of liquid crystals, when current liquid crystal vendors could not meet their technical requirements.
The Ohio Third Frontier Award will allow ChemImage to continue its collaboration with the Liquid Crystal Institute and establish a permanent manufacturing facility for ChemImage Imaging Technologies in Northeast Ohio, with about twenty jobs expected within the next two to five years of operation.
In addition to its Ohio expansion, ChemImage launched Gateway Analytical, an analytical testing company, last fall in Gibsonia, Pa.
For more information on ChemImage's filter technology, hyperspectral imaging instrumentation or software, visit the company's website at www.chemimage.com.
Sr. Marketing Communications Specialist
Phone: (412) 241-7335, ext. 291
ChemImage Corporation, a leader in hyperspectral imaging technology (i.e., molecular chemical imaging), provides instrumentation, software, contract services and expert consulting to government, industrial and academic organizations. The company's proprietary, state-of-the-art Hyperspectral Imaging technology has many applications, including defense, security, pharmaceuticals, forensics and biomedical diagnostic research, which can reveal critical chemical and biological information from a variety of material systems.
ChemImage's headquarters are located in Pittsburgh, Pa., where it houses research and development laboratories, as well as engineering and manufacturing facilities.
This information was brought to you by Cision http://www.cisionwire.com
The following files are available for download: